Pharma Mar, S.A. (OTCMKTS:PHMMF - Get Free Report)'s stock price traded up 18.9% during mid-day trading on Monday . The company traded as high as $96.20 and last traded at $96.20. 100 shares were traded during trading, a decline of 89% from the average session volume of 943 shares. The stock had previously closed at $80.91.
Pharma Mar Stock Performance
The company has a debt-to-equity ratio of 0.14, a quick ratio of 2.01 and a current ratio of 2.55. The stock's 50 day simple moving average is $88.01 and its 200-day simple moving average is $87.58.
Pharma Mar Company Profile
(
Get Free Report)
Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.
See Also
Before you consider Pharma Mar, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pharma Mar wasn't on the list.
While Pharma Mar currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
